Heidi Crane noted a $0.3 million increase in net interest expense, which slightly offset operational gains. Net Revenue -- ...

Strathmore’s 2026 fees bylaw has officially been cemented as of the Nov. 6 council meeting, coming just ahead of the imminent budget deliberations.

Appointed key leadership to drive (Z)-endoxifen development and evolve pathway to commercialization SEATTLE, /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a ...